Regulación del splicing alternativo: Implicaciones en el diagnóstico y tratamiento del cáncer

作者: Nancy Martínez-Montiel , Nora Rosas-Murrieta , Rebeca Martínez-Contreras

DOI: 10.1016/J.MEDCLI.2014.02.021

关键词: HumanitiesMedicine

摘要: Resumen La expresion de la informacion genetica es regulada por procesos como el splicing del ARN mensajero, mecanismo propuesto Phil Sharp y Richard Roberts, quienes demostraron existencia secuencias intronicas, las cuales interrumpen a mayoria los genes estructurales en eucariotes deben ser removidas con gran precision. Dicha remocion intrones se denomina , permite generar variantes proteicas partir un solo gen, cada una funciones diversas y, menudo, antagonicas. Actualmente sabe que principal fuente diversidad proteica, ya 70% humanos lo sufren, defectos este proceso originan hasta 50% enfermedades geneticas, incluido cancer. Cuando estos presentan involucrados adhesion, proliferacion ciclo celular, repercuten progresion cancerosos cuyo diagnostico, tratamiento prognosis puede determinarse base su perfil .

参考文章(51)
P. Förch, J. Valcárcel, Splicing Regulation in Drosophila Sex Determination Regulation of Alternative Splicing. ,vol. 31, pp. 127- 151 ,(2003) , 10.1007/978-3-662-09728-1_5
Agnieszka Piekielko-Witkowska, Hanna Wiszomirska, Anna Wojcicka, Piotr Poplawski, Joanna Boguslawska, Zbigniew Tanski, Alicja Nauman, Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors PLoS ONE. ,vol. 5, pp. e13690- ,(2010) , 10.1371/JOURNAL.PONE.0013690
Yoshihiko Kotake, Koji Sagane, Takashi Owa, Yuko Mimori-Kiyosue, Hajime Shimizu, Mai Uesugi, Yasushi Ishihama, Masao Iwata, Yoshiharu Mizui, Splicing factor SF3b as a target of the antitumor natural product pladienolide Nature Chemical Biology. ,vol. 3, pp. 570- 575 ,(2007) , 10.1038/NCHEMBIO.2007.16
Melissa S. Jurica, Melissa J. Moore, Pre-mRNA Splicing: Awash in a Sea of Proteins Molecular Cell. ,vol. 12, pp. 5- 14 ,(2003) , 10.1016/S1097-2765(03)00270-3
Julian P Venables, Roscoe Klinck, ChuShin Koh, Julien Gervais-Bird, Anne Bramard, Lyna Inkel, Mathieu Durand, Sonia Couture, Ulrike Froehlich, Elvy Lapointe, Jean-François Lucier, Philippe Thibault, Claudine Rancourt, Karine Tremblay, Panagiotis Prinos, Benoit Chabot, Sherif Abou Elela, Cancer-associated regulation of alternative splicing. Nature Structural & Molecular Biology. ,vol. 16, pp. 670- 676 ,(2009) , 10.1038/NSMB.1608
S. A. Forbes, N. Bindal, S. Bamford, C. Cole, C. Y. Kok, D. Beare, M. Jia, R. Shepherd, K. Leung, A. Menzies, J. W. Teague, P. J. Campbell, M. R. Stratton, P. A. Futreal, COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Research. ,vol. 39, pp. 945- 950 ,(2011) , 10.1093/NAR/GKQ929
Makoto Hasegawa, Tatsuhiro Miura, Kouji Kuzuya, Ayu Inoue, Se Won Ki, Sueharu Horinouchi, Tetsuo Yoshida, Tatsuki Kunoh, Koichi Koseki, Koshiki Mino, Ryuzo Sasaki, Minoru Yoshida, Tamio Mizukami, Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product. ACS Chemical Biology. ,vol. 6, pp. 229- 233 ,(2011) , 10.1021/CB100248E
Robert B. Darnell, Juan Valcárcel, Angela Relógio, Claudia Ben-Dov, Michael Baum, Matteo Ruggiu, Christine Gemund, Vladimir Benes, Alternative Splicing Microarrays Reveal Functional Expression of Neuron-specific Regulators in Hodgkin Lymphoma Cells Journal of Biological Chemistry. ,vol. 280, pp. 4779- 4784 ,(2005) , 10.1074/JBC.M411976200
Chiranthani Sumanasekera, David S. Watt, Stefan Stamm, Substances that can change alternative splice-site selection. Biochemical Society Transactions. ,vol. 36, pp. 483- 490 ,(2008) , 10.1042/BST0360483
Olga Anczuków, Avi Z Rosenberg, Martin Akerman, Shipra Das, Lixing Zhan, Rotem Karni, Senthil K Muthuswamy, Adrian R Krainer, The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation Nature Structural & Molecular Biology. ,vol. 19, pp. 220- 228 ,(2012) , 10.1038/NSMB.2207